Showing results (301-310 of 498) with videos related to
Sort By:
Pageof 50
CPT: Pharmacometrics & Systems Pharmacology|September 25, 2021
A multistate transition model for statin-induced myopathy and statin discontinuationYuxi Zhu, Chien-Wei Chiang, Lei Wang, et al.International Journal of Medical Informatics|January 3, 2006
A comparative study of mobile electronic data entry systems for clinical trials data collectionElodia Cole, Etta D Pisano, Gregory J Clary, et al.Pharmacogenomics|December 7, 2018
Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohortKyle Melin, Jee-Young Moon, Qibin Qi, et al.Statistics in Medicine|October 29, 2015
Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategyEric B Laber, Ying-Qi Zhao, Todd Regh, et al.Journal of Clinical Gastroenterology|October 1, 1988
Metastatic septic endophthalmitis in pyogenic liver abscessC T Chiu, D Y Lin, Y F LiawInternational Journal of Obesity (2005)|October 19, 2006
Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?C-M Chu, D-Y Lin, Y-F LiawBiometrics|December 1, 1991
Exact statistical inference for group sequential trialsD Y Lin, L J Wei, D L DeMetsJournal of Clinical Ultrasound : JCU|July 1, 1989
Hepatic parenchymal calcifications--differentiation from intrahepatic stonesH H Lin, C S Changchien, D Y LinStatistics in Medicine|May 15, 1993
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trialsD Y Lin, M A Fischl, D A SchoenfeldTissue Antigens|February 1, 1987
The distribution of HLA-A, B, C, DR antigens in Chinese patients with hepatocellular carcinoma in TaiwanD Y Lin, Y E Liaw, C C HuangPageof 50